AlphaYouDT
Schedule 13D filing
Dyer Timothy Mark disclosed a 9% stake in Addex Therapeutics Ltd. (ADXN)
Dyer Timothy Mark reported owning 9% of Addex Therapeutics Ltd. (ADXN) (19,165,714 shares) in a Schedule 13D filed Sep 4, 2026.
A 13D means the holder may push for changes at the company.
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.